Home » Latest » U.S. » New Warning Of Rare Coronavirus Complication In Children

New Warning Of Rare Coronavirus Complication In Children

3

InfoSearched 47 0 U.S.

5.6

SaveSavedRemoved 3

A mysterious illness striking children weeks after mild COVID-19 infections has doctors on two continents racing for answers.

Pediatricians in the United States and Europe have flagged nearly 100 cases of a rare, severe inflammatory condition in children believed to be linked to the novel coronavirus. The illness doesn’t look like the respiratory disease sweeping through adults — it hits weeks later, mimics other childhood syndromes, and can send a previously healthy kid into shock within days. Leading doctors have joined the World Health Organization, the CDC and the NIH in urgent information-sharing sessions to figure out what they’re dealing with.

• Nearly 100 cases have been reported across the U.S. and Europe of a severe inflammatory condition suspected to be tied to coronavirus in children.
• Patients typically show up weeks after a mild or unnoticed initial infection, testing positive for antibodies rather than active viral RNA.
• The illness mirrors Kawasaki disease and toxic shock syndrome — high fever, abdominal pain, vomiting, rash, and in the worst cases, cardiogenic shock.

An Illness That Doesn’t Fit the Pattern

For months, the reassuring line about COVID-19 has been that children largely escape the severe respiratory illness seen in adults. This new syndrome breaks that pattern entirely. Rather than gasping for breath, affected kids arrive with prolonged high fevers, severe abdominal pain, vomiting, diarrhea, skin rash and conjunctivitis — a constellation that looks far more like Kawasaki disease or toxic shock syndrome than a lung infection.

What’s throwing clinicians is the timing. Many of these patients aren’t testing positive for active virus at all — they’re testing positive for antibodies, meaning the infection that triggered the reaction may have happened weeks earlier and gone unnoticed or produced only mild symptoms the first time around. That delayed, immune-driven presentation is why doctors describe this less as a COVID complication in the usual sense and more as an aftershock.

From Intensive Care Units to an International Alert

British health authorities were the first to sound the alarm in late April, after intensive care units across the United Kingdom recorded a cluster of children with the same unusual presentation. The pattern didn’t stay contained to Britain. Pediatric hospitals across the New York metropolitan area — among the hardest-hit regions in the country — began reporting dozens of critically ill children showing identical symptoms, prompting doctors there to compare notes with their counterparts overseas almost in real time.

That transatlantic exchange is what pulled in the WHO, the CDC and the NIH. Health organizations moved quickly to convene working groups aimed at nailing down diagnostic criteria so front-line doctors — many of whom had never seen anything like it — would know what to look for and how fast to escalate to cardiac monitoring.

Doctors are seeing elevated cardiac enzymes and coronary artery enlargement or aneurysms in children who, days earlier, appeared completely healthy.

Treating the Complication

Because the syndrome can progress rapidly to cardiogenic shock or systemic vascular inflammation, hospitalized children have needed intensive care, with treatment centered on intravenous immunoglobulin or steroids — the same tools used against Kawasaki disease. The overlap in cardiac findings, including enlarged coronary arteries, is one reason specialists are drawing the Kawasaki comparison rather than treating this as a brand-new disease from scratch, even as they stress it isn’t a perfect match.

Families navigating school decisions and childcare during the pandemic — a struggle already documented in reporting on how schools face tough choices about reopening — now have another variable to weigh, even as doctors emphasize the condition remains very rare relative to the overall number of pediatric COVID-19 infections.

Doctors Urge Calm Over Panic

Medical experts repeatedly stressed the same point: this remains a rare occurrence set against the much larger pool of children who’ve been infected with the virus and had mild or no symptoms at all, a group whose experience has been chronicled in accounts like one 16-year-old’s hospitalizations with COVID-19. The message from clinicians isn’t that every fever is cause for alarm — it’s that parents and pediatricians need a clear symptom checklist so the rare severe cases get caught before they progress to shock.

The working groups pulled together by the WHO, CDC and NIH are now racing to standardize that checklist across hospitals on both sides of the Atlantic, so a child showing up in an ER in Queens gets the same rapid cardiac workup as one in London — before the fever and the rash tip into something doctors can’t reverse.